DTC "Brief Summary" Should Refer To Other Treatment Options, Blues Tell FDA

Prescribing information for direct-to-consumer ads should include a tagline encouraging consumers to consult their doctors for other treatment options, the Blue Cross/Blue Shield Association comments on FDA's DTC draft guidances say.

More from Archive

More from Pink Sheet